Alice Tracey
Alice Tracey


Alice is a reporter with The Cancer Letter. She joined the publication in 2021.

Alice has a background in engineering and scientific research, having earned a B.S.E in Biomedical Engineering from the University of Michigan, Ann Arbor (2020). While in college, she wrote for Michigan’s independent student newspaper, The Michigan Daily, and went on to pursue science journalism. She has a Master’s in Creative and Critical Writing from the University of London, Birkbeck (2021).

Latest Stories

Capitol Hill
The House of Representatives on June 22 voted 336-85 to pass legislation that would establish the authorities of the Advanced Research Projects Agency-Health (ARPA-H), President Joe Biden’s proposed high-risk, high-reward biomedical research agency.
NCI is moving forward with a plan to evaluate multi-cancer early detection tests, a technology that is rapidly making inroads into the healthcare system.  
The NCI Board of Scientific Advisors unanimously approved eight new concepts and nine reissued concepts at a meeting June 13-15. 
NCI and Cancer Research UK have awarded $100 million in total funding through the Cancer Grand Challenges program, supporting research into solid tumors in children, cachexia, extrachromosomal DNA, and tumor development.
NCI Director's Report
In the next phase of the Cancer Moonshot, NCI will focus on investing in the development and testing of new modalities, including multi-cancer early detection assays, and fostering diversity in oncology, NCI Acting Director Douglas R. Lowy said at a joint meeting of the Board Of Scientific Advisors and the National Cancer Advisory Board.